DI BELLA METHOD
>
DOCUMENTATION INDEX > SCIENTIFIC WORKS
Melatonin Anticancer Effects: Review
(31/01/2013)
Detail
Monitoring intracellular melatonin levels in human prostate normal and cancer cells by HPLC.
(06/05/2011)
Detail
M elatonin, a promising role in taxane-related neuropathy.
(06/05/2011)
Detail
Melatonin and vitamin D(3) synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells.
(06/05/2011)
Detail
In vitro and in vivo antitumor activity of melatonin receptor agonists
(06/05/2011)
Detail
International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.
(06/05/2011)
Detail
Melatonin and metformin inhibit skin carcinogenesis induced by benz(a)pyrene in mice
(06/05/2011)
Detail
Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.
(06/05/2011)
Detail
Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) and ERalpha in MCF-7 human breast cancer cells
(06/05/2011)
Detail
Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells.
(06/05/2011)
Detail
Melatonin: a multitasking molecule.
(06/05/2011)
Detail
Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells.
(06/05/2011)
Detail
Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia.
(06/05/2011)
Detail
Clinical uses of melatonin: evaluation of human trials.
(06/05/2011)
Detail
Effect of melatonin on the expression of Nrf2 and NF-kappaB during cyclophosphamide-induced urinary bladder injury in rat.
(06/05/2011)
Detail